RecruitingEmphysemaCOPDSevere Emphysema
Zephyr Valve Japan Post-Marketing Surveillance
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.
Sponsor: Pulmonx Corporation
You may qualify if…
- ✓ 1. Patient is deemed eligible for BLVR using Zephyr Valve, as determined by their treating physician in accordance with Japanese guidelines and approved instruction for use. These include:
- ✓ Recent respiratory rehabilitation completed within the last 6 months
- ✓ Not actively smoking (for at least 4 months)
- ✓ TLC ≥ 100%
- ✓ RV ≥ 175%
- ✓ FEV1 15-45% post-bronchodilator
- ✓ 6MWD 100-500 m
- ✓ mMRC score ≥ 2
Source: ClinicalTrials.gov · NCT06332885 · last updated 2026-09-17